Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity
Clinical trial NCT05956509 · TERMINATED
Trial details
- NCT number
- NCT05956509
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-12
- Primary completion
- 2024-06-02
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.